New-onset IgG autoantibodies in hospitalized patients with COVID-19.
Sarah Esther Chang,Allan Feng,Wenzhao Meng,Sokratis A. Apostolidis,Elisabeth Mack,Maja Artandi,Linda Barman,Kate Bennett,Saborni Chakraborty,Iris Chang,Peggie Cheung,Sharon Chinthrajah,Shaurya Dhingra,Evan Do,Amanda Finck,Andrew Gaano,Reinhard Geßner,Heather M. Giannini,Joyce Gonzalez,Sarah Greib,Margrit Gündisch,Alex Ren Hsu,Alex J. Kuo,Monali Manohar,Rong Mao,Indira Neeli,Andreas Neubauer,Oluwatosin Oniyide,Abigail E. Powell,Rajan Puri,Harald Renz,Jeffrey M. Schapiro,Payton A. Weidenbacher,Richard Wittman,Neera Ahuja,Ho-Ryun Chung,Prasanna Jagannathan,Judith A. James,Peter S. Kim,Peter S. Kim,Nuala J. Meyer,Kari C. Nadeau,Marko Z. Radic,William H. Robinson,William H. Robinson,Upinder Singh,Taia T. Wang,E. John Wherry,Chrysanthi Skevaki,Eline T. Luning Prak,Paul J. Utz +50 more
Reads0
Chats0
TLDR
In this article, three protein arrays were developed to measure IgG autoantibodies associated with connective tissue diseases, anti-cytokine antibodies, and anti-viral antibody responses in serum from 147 hospitalized COVID-19 patients.Abstract:
COVID-19 is associated with a wide range of clinical manifestations, including autoimmune features and autoantibody production. Here we develop three protein arrays to measure IgG autoantibodies associated with connective tissue diseases, anti-cytokine antibodies, and anti-viral antibody responses in serum from 147 hospitalized COVID-19 patients. Autoantibodies are identified in approximately 50% of patients but in less than 15% of healthy controls. When present, autoantibodies largely target autoantigens associated with rare disorders such as myositis, systemic sclerosis and overlap syndromes. A subset of autoantibodies targeting traditional autoantigens or cytokines develop de novo following SARS-CoV-2 infection. Autoantibodies track with longitudinal development of IgG antibodies recognizing SARS-CoV-2 structural proteins and a subset of non-structural proteins, but not proteins from influenza, seasonal coronaviruses or other pathogenic viruses. We conclude that SARS-CoV-2 causes development of new-onset IgG autoantibodies in a significant proportion of hospitalized COVID-19 patients and are positively correlated with immune responses to SARS-CoV-2 proteins.read more
Citations
More filters
Journal ArticleDOI
Multiple early factors anticipate post-acute COVID-19 sequelae
Yapeng Su,Dan Yuan,Daniel G. Chen,Rachel Ng,Kai Wang,Jongchan Choi,Sarah Li,Sunga Hong,Rongyu Zhang,Jingyi Xie,Sergey A. Kornilov,Kelsey Scherler,A.-J. Pavlovitch-Bedzyk,Shen Dong,Christopher Lausted,Inyoul Lee,Shannon Fallen,Chengzhen L. Dai,Priyanka Baloni,Brett Smith,Venkata R. Duvvuri,Kristin G. Anderson,Jing Wei Li,Fan Yang,Caroline J. Duncombe,Denise J. McCulloch,Clifford Rostomily,Pamela Troisch,Jing Zhou,Sean Mackay,Quinn DeGottardi,Damon May,Ruth T. Taniguchi,Rachel M. Gittelman,Mark Klinger,Thomas M. Snyder,Ryan Roper,Gladys Wojciechowska,Kim Murray,Rick Edmark,Simon Evans,Lesley Jones,Yon-gan Zhou,Lee Rowen,Rachel Xia-Ying Liu,William Chour,Heather Algren,William R. Berrington,Julie A. Wallick,Rebecca Cochran,Mary Micikas,Christos J. Petropoulos,Hunter Cole,Trevan D Fischer,Wei Wei,Dave S.B. Hoon,Nathan D. Price,Naeha Subramanian,Joshua A. Hill,Jenn J. Hadlock,Andrew T. Magis,Antoni Ribas,Lewis L. Lanier,Scott D. Boyd,Jeffrey A. Bluestone,Helen Y. Chu,Leroy Hood,Raphael Gottardo,Philip D. Greenberg,Mark M. Davis,Jason D Goldman,James R. Heath +71 more
TL;DR: Huang et al. as discussed by the authors performed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2-3 months later), integrated with clinical data and patient-reported symptoms.
Journal ArticleDOI
The immunology and immunopathology of COVID-19
TL;DR: It is hoped that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.
Journal ArticleDOI
Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang,Paul Bastard,Adem Karbuz,A Gervais,Ahmad N. Abou Tayoun,Alessandro Aiuti,Alexandre Belot,Alexandre Bolze,Alexandre Gaudet,Anastasiia Bondarenko,Zhiyong Liu,András N Spaan,Andrea Guennoun,Andrés Augusto Arias,A. Planas,Anna Sediva,Anna Shcherbina,Anna-Lena Neehus,Anne Puel,Antoine Froidure,Antonio Novelli,Aslınur Özkaya Parlakay,Aurora Pujol,Aysun Yahşi,Belgin Gülhan,Benedetta Bigio,Bertrand Boisson,Beth A. Drolet,Carlos Andrés Arango Franco,Carlos Flores,Carlos Rodríguez-Gallego,Carolina Prando,Catherine M. Biggs,Charles-Edouard Luyt,Clifton L. Dalgard,Cliona O'Farrelly,Daniela Matuozzo,David Dalmau,David S. Perlin,Davood Mansouri,Diederik van de Beek,Donald C. Vinh,Elena Domínguez-Garrido,Elena W Y Hsieh,Emine Hafize Erdeniz,Emmanuelle Jouanguy,Esra Şevketoğlu,Estelle Talouarn,Eugenia Quiros-Roldan,Evangelos Andreakos,Eystein S. Husebye,Fahad Alsohime,Filomeen Haerynck,Giorgio Casari,G. Novelli,Gokhan Aytekın,Guillaume Morelle,Gülsüm Alkan,Gülsüm İclal Bayhan,Hagit Baris Feldman,Helen C. Su,Horst von Bernuth,Igor Resnick,Ingrid G Bustos,Isabelle Meyts,Isabelle Migeotte,Ivan Tancevski,Jacinta Bustamante,Jacques Fellay,Jamila El Baghdadi,Javier Martinez-Picado,Jérémie Rosain,Jeremy Manry,Jie Chen,John Christodoulou,J. B. Bohlen,José Luis Franco,Juan Li,Juan-Manuel Anaya,Julian Castaño Rojas,Junqiang Ye,K. M. Furkan Uddin,Kadriye Kart Yaşar,Kai Kisand,Keisuke Okamoto,Khalil Chaïbi,K. Mironska,László Maródi,Laurent Abel,Laurent Rénia,Lazaro Lorenzo,Lennart Hammarström,Lisa F. P. Ng,Lluis Quintana-Murci,Lucía Victoria Erazo,Luigi D. Notarangelo,Luis F. Reyes,Luis M. Allende,Luisa Imberti,Majistor Raj Luxman Maglorius Renkilaraj,Marcela Moncada-Vélez,Marie Materna,Mark E. Anderson,Marta Gut,Marwa Chbihi,Masato Ogishi,Melike Emiroglu,Mikko Seppänen,Mohammed Jasim Uddin,Mohammed Shahrooei,Natalie Carter Alexander,Nevin Hatipoğlu,Nico Marr,Nihal Akçay,Oksana Boyarchuk,Ondrej Slaby,O Akcan,Peng Zhang,Pere Soler-Palacín,Peter K. Gregersen,Petter Brodin,Pierre Garçon,Pierre-Emmanuel Morange,Qiang Pan-Hammarström,Qinhua Zhou,Quentin Philippot,Rabih Halwani,Rebeca Pérez de Diego,Romain Lévy,Rui-Fu Yang,Şadiye Kübra Tüter Öz,Saleh Al Muhsen,Saliha Kanık-Yüksek,Sara Elva Espinosa-Padilla,Sathishkumar Ramaswamy,Satoshi Okada,Sefika Elmas Bozdemir,Selma Erol Aytekin,Şemsi Nur Karabela,Sevgi Keles,Sevtap Şenoğlu,Shen-ying Zhang,Sotirija Duvlis,Stefan N. Constantinescu,Stéphanie Boisson-Dupuis,Stuart E. Turvey,Stuart G. Tangye,Takaki Asano,Tayfun Ozcelik,Tom Le Voyer,Tom Maniatis,Tomohiro Morio,Trine H. Mogensen,Vanessa Sancho-Shimizu,Vivien Béziat,Xavier Solanich,Yenan T. Bryceson,Y.L. Lau,Yuval Itan,Aurélie Cobat,Jean-Laurent Casanova +160 more
TL;DR: In this article , the molecular and cellular determinants of critical COVID-19 pneumonia were reviewed and the TLR3- and TLR7-dependent production of type I interferons by respiratory epithelial cells and plasmacytoid dendritic cells, respectively, is essential for host defence against SARS-CoV-2 infection.
Journal ArticleDOI
Unexplained post-acute infection syndromes
TL;DR: In this paper , the authors summarize what is known about unexplained PAISs, provide context for post-acute sequelae of SARS-CoV-2 infection (PASC), and delineate the need for basic biomedical research into the underlying mechanisms behind this group of enigmatic chronic illnesses.
Journal ArticleDOI
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Michael J. Peluso,Scott Lu,Alex F Tang,Matthew S Durstenfeld,Hsi-En Ho,Sarah A Goldberg,Carrie A Forman,Sadie E. Munter,Rebecca Hoh,Viva W. Tai,Ahmed Chenna,Brandon C. Yee,John Winslow,Christos J. Petropoulos,Bryan Greenhouse,Peter W. Hunt,Priscilla Y. Hsue,Jeffrey N. Martin,J. Daniel Kelly,David V. Glidden,Steven G. Deeks,Timothy J. Henrich +21 more
TL;DR: In this paper, the authors measured soluble markers of inflammation in a SARS-CoV-2 recovery cohort at early ( 90 days) timepoints and compared fold-changes in marker values between those with and without PASC using mixed-effects models with terms for PASC and early and late recovery time periods.
References
More filters
Journal ArticleDOI
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.
Carl W. Davis,Katherine J. L. Jackson,Katherine J. L. Jackson,Anita K. McElroy,Anita K. McElroy,Anita K. McElroy,Peter Halfmann,Jessica Huang,Chakravarthy Chennareddy,Ashley E. Piper,Yvonne Leung,César G. Albariño,Ian Crozier,Ali H. Ellebedy,Ali H. Ellebedy,John Sidney,Alessandro Sette,Alessandro Sette,Tianwei Yu,Sandra C. A. Nielsen,Arthur J. Goff,Christina F. Spiropoulou,Erica Ollman Saphire,Erica Ollman Saphire,Guy Cavet,Yoshihiro Kawaoka,Yoshihiro Kawaoka,Aneesh K. Mehta,Pamela J. Glass,Scott D. Boyd,Rafi Ahmed +30 more
TL;DR: This study provides a benchmark for assessing EBOV vaccine-induced immunity, with striking changes occurred in the immunoglobulin repertoire, with massive recruitment of naive B cells that subsequently underwent hypermutation.
Posted ContentDOI
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
Pranay R. Randad,Nora Pisanic,Kate Kruczynski,Yukari C. Manabe,David L. Thomas,Andrew Pekosz,Sabra L. Klein,Michael J. Betenbaugh,William Clarke,Oliver Laeyendecker,Oliver Laeyendecker,Patrizio Caturegli,H. Benjamin Larman,Barbara Detrick,Jessica K. Fairley,Amy C Sherman,Nadine Rouphael,Srilatha Edupuganti,Douglas A. Granger,Steve W. Granger,Matthew H. Collins,Christopher D. Heaney +21 more
TL;DR: SARS-CoV-2 antibody testing in saliva can play a critically important role in large-scale 'sero'-surveillance to address key public health priorities and guide policy and decision-making for COVID-19.
Journal ArticleDOI
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19
Teluguakula Narasaraju,Benjamin Tang,Martin Herrmann,Sylviane Muller,Vincent T. K. Chow,Marko Z. Radic +5 more
TL;DR: The need to develop therapies aimed at inhibiting neutrophil recruitment, activation, degranulation, and neutrophIL extracellular trap (NET) release is argued and currently available pharmacologic approaches should be tested as treatments for ARDS in COVID-19.
Journal ArticleDOI
A case of subacute thyroiditis associated with Covid-19 infection.
E Asfuroglu Kalkan,Ihsan Ates +1 more
TL;DR: A 41-year-old Caucasian woman with no previous medical history was referred to internal medicine department with fever and neck pain and was discharged on prednisolone tapering dose for 4 weeks with outpatient follow-up, which showed significant improvement of clinical condition.
Journal ArticleDOI
Clonal Evolution of Autoreactive Germinal Centers.
Søren E. Degn,Søren E. Degn,Cees E. van der Poel,Daniel J. Firl,Daniel J. Firl,Burcu Ayoglu,Fahd A. Al Qureshah,Fahd A. Al Qureshah,Goran Bajic,Luka Mesin,Claude-Agnès Reynaud,Jean-Claude Weill,Paul J. Utz,Gabriel D. Victora,Michael C. Carroll +14 more
TL;DR: A novel mouse model where the presence of a single autoreactive B cell clone drives the TLR7-dependent activation, expansion, and differentiation of other autore active B cells in spontaneous GCs is presented, providing insight into the maturation of the self-reactive B Cell response.
Related Papers (5)
New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19
Sarah Esther Chang,Allan Feng,Wenzhao Meng,Sokratis A. Apostolidis,Elisabeth Mack,Maja Artandi,Linda Barman,Kate Bennett,Saborni Chakraborty,Iris Chang,Peggie Cheung,Sharon Chinthrajah,Shaurya Dhingra,Evan Do,Amanda Finck,Andrew Gaano,Reinhard Geßner,Heather M. Giannini,Joyce Gonzalez,Sarah Greib,Margrit Gündisch,Alex Ren Hsu,Alex J. Kuo,Monali Manohar,Rong Mao,Indira Neeli,Andreas Neubauer,Oluwatosin Oniyide,Abigail E. Powell,Rajan Puri,Harald Renz,Jeffrey M. Schapiro,Payton A. Weidenbacher,Richard Wittman,Neera Ahuja,Ho-Ryun Chung,Prasanna Jagannathan,Judith A. James,Peter S. Kim,Nuala J. Meyer,Kari C. Nadeau,Marko Z. Radic,William H. Robinson,William H. Robinson,Upinder Singh,Taia T. Wang,E. John Wherry,Chrysanthi Skevaki,Eline T. Luning Prak,Paul J. Utz +49 more